Position in CORT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,568,725
+$24,064,648 QoQ
Shares Held
328,565
+194.1% QoQ
Ownership
0.304%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 423 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in CORT Over Time
Shares Held
Position Value (USD)
Derivatives in CORT
reported options exposure · as of Mar 31, 2023CallValue
$18,194,400
CallShares
840,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. CORT ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in CORT
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,568,725 | 328,565 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,504,077 | 111,736 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,911,296 | 83,658 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $9,248,478 | 111,280 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $10,096,240 | 137,551 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,987,371 | 139,970 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,971,171 | 98,654 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,467,969 | 161,365 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,681,005 | 174,854 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,961,785 | 673,354 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,334,847 | 287,403 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,101,497 | 187,211 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,190,377 | 98,444 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,194,400 | 840,000 | Call | Defined | 2023-05-12 | |
| 2023-03-31 | $2,417,187 | 111,597 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,007,823 | 98,859 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,133,706 | 83,218 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,294,006 | 96,468 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,343,676 | 104,071 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,337,170 | 168,544 | Shares | Defined | 2022-02-08 | |
| 2021-12-31 | $12,474,000 | 630,000 | Call | Defined | 2022-02-08 | |
| 2021-09-30 | $984,000 | 50,000 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $4,177,629 | 212,278 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $984,000 | 50,000 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $3,675,298 | 167,059 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $5,189,310 | 218,130 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,873,360 | 109,838 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,625,879 | 150,826 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,329,334 | 79,033 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,037,532 | 87,261 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||